Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

The Lancet

Volumn 373, Issue 9663, 2009, Pages 557-566

  Gomes, MF ^a   Faiz, MA ^b   Gyapong, JO ^c   Warsame, M ^a   Agbenyega, T ^d   Babiker, A ^e   Baiden, F ^f   Yunus, EB ^g   Binka, F ^h   Clerk, C ⁱ   Folb, P ^j   Hassan, R ^g   Hossain, MA ^g   Kimbute, O ^k   Kitua, A ^k   Krishna, S ^l   Makasi, C ^k   Mensah, N ^m   Mrango, Z ^k   Olliaro, P ^a   Peto, R ⁿ   Peto, TJ ^o   Rahman, MR ^p   Ribeiro, I ^q   Samad, R ^g   White, NJ ^r   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTRY OF HEALTH AND FAMILY WELFARE   (Bangladesh)

^c Health Research Unit Ghana Health Service   (Ghana)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f World Health Organisation United Republic of Tanzania   (Tanzania)

^g CHITTAGONG MEDICAL COLLEGE   (Bangladesh)

^h UNIVERSITY OF GHANA   (Ghana)

ⁱ Dodowa Health Research Centre   (Ghana)

^j SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^k NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^l ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^m NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^p Begum Khaleda Zia Medical College   (Bangladesh)

^q DNDi   (Brazil)

^r MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BANGLADESH; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; FEMALE; GHANA; HEALTH CARE ACCESS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; SINGLE DRUG DOSE; SUPPOSITORY; TANZANIA;

EID: 59949100121     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61734-1     Document Type: Article

References (18)

1. for the Disease Control Priorities Project. Global burden of disease and risk factors. In: Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J.L. (Eds) (2006), The World Bank/Oxford University Press, New York
2. Newton C.R.J.C., and Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 79 (1998) 1-53
3. Molyneux M.E. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71 (1989) 441-459
4. Carter J.A., Mung'ala-Odera V., Neville B.G.R., et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry 76 (2005) 476-481
5. Ngoungou E.B., Dulac O., Poudiougou B., et al. Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia 47 (2006) 873-879
6. White N.J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41 (1997) 1413-1422
7. Simpson J.A., Agbenyega T., Barnes K.I., et al. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med 3 (2006) e444
8. Krishna S., Planche T., Agbenyega T., et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother 45 (2001) 509-516
9. Barnes K.I., Mwenechanya J., Tembo M., et al. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet 363 (2004) 1598-1605
10. Brewer T.G., Peggins J.O., Grate S.J., et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 suppl 1 (1994) S33-S36
11. Dondorp A., Nosten F., Stepniewska K., Day N.P., and White N.J. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366 (2005) 717-725
12. White N.J. Antimalarial drug resistance and mortality in falciparum malaria. Trop Med Int Health 4 (1999) 469
13. White N.J. Antimalarial resistance. J Clin Invest 113 (2004) 1084-1092
14. Arrow K.J., Panosian C.B., and Gelband H. Saving lives, buying time: economics of malaria drugs in an age of resistance (2004), National Academy Press, Washington
15. Peterson S., Nsungwa-Sabiiti J., Were W., et al. Coping with paediatric referral-Ugandan parents' experience. Lancet 363 (2004) 1955-1956
16. al Fadil S.M., Alrahman S.H., Cousens S., et al. Integrated Management of Childhood Illness strategy: compliance with referral and follow-up recommendations in Gezira State, Sudan. Bull World Health Organ 81 (2003) 708-716
17. Chowdhury E.K., El Arifeen S., Rahman M., et al. Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study. Lancet 372 (2008) 822-830
18. Yunus E.B., Faiz M.A., Rahman M.R., et al. Study to document pre-admission risk factors for development of severe malaria and the spectrum of it and the outcome in different categories of hospitals in malaria endemic zone of Bangladesh. J Bang Coll Phys Surg 22 (2004) 83-88